Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

The Dales Report

28 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Uncategorized

Sales Of Johnson & Johnson Esketamine Drug Spravato Rise Nearly 100% Year Over Year

By The Dales Report
July 20, 3:14 PM
Global pharmaceutical behemoth Johnson & Johnson (NYSE: JNJ) today announced results for their fiscal second quarter 2023.

JNJ

Read More
2 minute read
  • Analyst Ratings
  • Cannabis
  • Markets
  • Penny Stocks
  • Psychedelics
  • Small Cap

Eight Capital Analyst Believes Canopy Should Not Be Valued As A Going Concern, Price Target $0

By The Dales Report
July 12, 10:09 AM
TerrAscend Corp. (OTC: TSNDF) has had a watershed moment, and Canopy Growth (NASDAQ: CGC) reaches $0 price target. Welcome to our latest Trade to Black podcast.

CGC

Read More
2 minute read
  • Small Cap

COMPASS Pathways Projects 2027 Commercialization Timeline For Psilocybin Therapy

By The Dales Report
July 7, 11:13 AM
With timelines for the submission of approval for MDMA-assisted therapy becoming more clear, COMPASS Pathways (NASDAQ: CMPS) has provided their o

CMPS

Read More
2 minute read
  • Uncategorized

Binance Withdraws Support For Several Tokens With Links To The Multichain Bridge

By The Dales Report
July 6, 9:28 AM
Binance, the largest cryptocurrency exchange by volume, has withdrawn support for eight multichain bridged tokens, effective July 7, 2023.

$ALPACA

Read More
2 minute read
  • Cannabis
  • General
  • Government
  • Health Care
  • Markets
  • Penny Stocks
  • Psychedelics
  • Regulations

Numinus Partners With MAPS To Conduct Phase 1 MDMA Assisted Therapy Investigational Study

By The Dales Report
June 16, 1:06 PM
In a prelude to what is hoped will be regulatory approval of MDMA-assisted therapy in the U.S. and Canada, Numinus Wellness Inc. (OTC: NUMIF) has taken steps to get out in front of the curve.

NUMIF

Read More
2 minute read
  • Markets
  • Psychedelics

Red Light Holland’s Shroom Outlook – Todd Shapiro Reveals All

By The Dales Report
May 22, 1:00 PM
Cannabis earnings has been dominating the news lately, but in this latest TDR Psychedelic Exclusive, we turn back…

CSE:TRIP

Read More
2 minute read
  • Penny Stocks

FCM Holdings Accuse MindMed Braintrust Of ‘Pursuing Misguided Clinical Path for MM-120’

By The Dales Report
May 16, 11:33 AM
Mind Medicine (NASDAQ: MNMD) activist shareholders FCM MM Holdings are at it again.

MNMD

Read More
2 minute read
  • Penny Stocks

MindMed CEO On Latest Positive Topline Phase 2 Data And Freedom Capital Management

By The Dales Report
April 26, 12:16 PM
In this new Psychedelics Exclusive podcast, TDR Founder Shadd Dales interviewed the CEO of Mind Medicine Inc. (NASDAQ: MNMD), Robert Barrow.

MNMD

Read More
2 minute read
  • Penny Stocks

Numinus Wellness CEO Payton Nyquvest On Q2 2023 Financial Results And Numinus Network

By The Dales Report
April 19, 12:55 PM
On this new Psychedelic Series Podcast, TDR Founder Shadd Dales spoke with Payton Nyquvest, CEO of Numinus Wellness Inc. (OTC: NUMIF).

NUMIF

Read More
3 minute read
  • Uncategorized

Citibank: $5 Trillion Of CBDCs Will Be Circulating In The Economy “By The End Of This Decade”

By The Dales Report
March 30, 2:32 PM
According to a latest report from Citibank (Citi) (NYSE: C) titled ‘Money, Tokens, and Games: Blockchain’s Next Billion Users and Trillions in Value‘ blockchain technology is approaching a

BTC

Posts pagination

Previous 1 2 3 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service